Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Angelo

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Myelin pathology is a key feature of X-linked Dystonia ParkinsonismPriya Prakash, Kerry C Limberg, Weimin Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Therapeutic targeting of alternative splicing caused by a lethal noncoding structural variant in X-linked dystonia parkinsonismRachita Yadav, Christine A Vaine, Aloysius Domingo, et al.
Acta Medica Philippina|July 5, 2024
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY TrialDeonne Thaddeus V Gauiran, Teresita E Dumagay, Mark Angelo C Ang, et al.
BMC Infectious Diseases|November 21, 2021
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Perrine Janiaud, Andreas M Schmitt, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Myelin pathology is a key feature of X-linked Dystonia ParkinsonismPriya Prakash, Kerry C Limberg, Weimin Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Therapeutic targeting of alternative splicing caused by a lethal noncoding structural variant in X-linked dystonia parkinsonismRachita Yadav, Christine A Vaine, Aloysius Domingo, et al.
Acta Medica Philippina|July 5, 2024
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY TrialDeonne Thaddeus V Gauiran, Teresita E Dumagay, Mark Angelo C Ang, et al.
BMC Infectious Diseases|November 21, 2021
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Perrine Janiaud, Andreas M Schmitt, et al.
Pageof 3